acetaminophen aspirin and caffeine

Generic: acetaminophen aspirin and caffeine

Labeler: Elysium Pharmaceutical Ltd
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Active

Drug Facts

Product Profile

Brand Name acetaminophen aspirin and caffeine
Generic Name acetaminophen aspirin and caffeine
Labeler Elysium Pharmaceutical Ltd
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ACETAMINOPHEN 250 mg/1, ASPIRIN 250 mg/1, CAFFEINE 65 mg/1

Identifiers & Regulatory

Product NDC 14803-135
Product ID 14803-135_49715a86-f118-2f36-e063-6394a90a0908
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2027-12-31
Marketing Start 2024-01-30

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 14803135
Hyphenated Format 14803-135

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetaminophen aspirin and caffeine (source: ndc)
Generic Name acetaminophen aspirin and caffeine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
  • 65 mg/1
source: ndc
Packaging
  • 30000 TABLET in 1 BOTTLE (14803-135-00)
source: ndc

Packages (1)

14803-135-00 30000 TABLET in 1 BOTTLE (14803-135-00)

Ingredients (3)

ACETAMINOPHEN (250 mg/1) ASPIRIN (250 mg/1) CAFFEINE (65 mg/1)

Linked Drug Pages (1)

acetaminophen aspirin and caffeine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "49715a86-f118-2f36-e063-6394a90a0908", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["1031c81e-ac26-4068-e063-6394a90a6e9d"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Elysium Pharmaceutical Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30000 TABLET in 1 BOTTLE (14803-135-00)", "package_ndc": "14803-135-00", "marketing_start_date": "20240130"}], "brand_name": "acetaminophen aspirin and caffeine", "product_id": "14803-135_49715a86-f118-2f36-e063-6394a90a0908", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "14803-135", "generic_name": "acetaminophen aspirin and caffeine", "labeler_name": "Elysium Pharmaceutical Ltd", "product_type": "HUMAN OTC DRUG", "brand_name_base": "acetaminophen aspirin and caffeine", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20240130", "listing_expiration_date": "20271231"}